Mayne Pharma Group Ltd (MAYNF)
4.46
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Mayne Pharma Group Price to Book Value: 1.017 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.017 |
| May 02, 2024 | 1.017 |
| May 01, 2024 | 1.017 |
| April 30, 2024 | 1.017 |
| April 29, 2024 | 1.017 |
| April 26, 2024 | 1.017 |
| April 25, 2024 | 1.017 |
| April 24, 2024 | 1.035 |
| April 23, 2024 | 1.035 |
| April 22, 2024 | 1.035 |
| April 19, 2024 | 1.019 |
| April 18, 2024 | 1.019 |
| April 17, 2024 | 1.019 |
| April 16, 2024 | 1.019 |
| April 15, 2024 | 1.019 |
| April 12, 2024 | 1.019 |
| April 11, 2024 | 1.019 |
| April 10, 2024 | 1.019 |
| April 09, 2024 | 1.019 |
| April 08, 2024 | 0.9731 |
| April 05, 2024 | 0.9731 |
| April 04, 2024 | 0.9731 |
| April 03, 2024 | 0.9775 |
| April 02, 2024 | 0.9775 |
| April 01, 2024 | 0.9775 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.9775 |
| March 27, 2024 | 0.9775 |
| March 26, 2024 | 0.9775 |
| March 25, 2024 | 0.9775 |
| March 22, 2024 | 0.9775 |
| March 21, 2024 | 0.9775 |
| March 20, 2024 | 0.9797 |
| March 19, 2024 | 0.9797 |
| March 18, 2024 | 0.9797 |
| March 15, 2024 | 0.9797 |
| March 14, 2024 | 0.9797 |
| March 13, 2024 | 0.9797 |
| March 12, 2024 | 0.9797 |
| March 11, 2024 | 0.9797 |
| March 08, 2024 | 0.9753 |
| March 07, 2024 | 0.9993 |
| March 06, 2024 | 0.9993 |
| March 05, 2024 | 0.9993 |
| March 04, 2024 | 0.9274 |
| March 01, 2024 | 0.9274 |
| February 29, 2024 | 0.9252 |
| February 28, 2024 | 0.9035 |
| February 27, 2024 | 0.7728 |
| February 26, 2024 | 0.7728 |
| February 23, 2024 | 0.7728 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3037
Minimum
Mar 19 2020
1.313
Maximum
Aug 16 2022
0.6758
Average
0.6712
Median
Jul 14 2020
Price to Book Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | 1.998 |
| Immutep Ltd | -- |
| Opthea Ltd | -- |
| Mesoblast Ltd | -- |
Price to Book Value Related Metrics
| PS Ratio | 2.076 |
| PEG Ratio | -0.0125 |
| Price | 4.46 |
| Earnings Yield | -44.41% |
| Market Cap | 379.43M |